Celyad Oncology SA
F:1C0
Celyad Oncology SA
F:1C0
Price:
0.18
EUR
-2.7%
Market Cap:
€2.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celyad Oncology SA
F:1C0
|
BE |
|
C
|
Centrotherm International AG
XMUN:CTNK
|
DE |
|
W
|
Wahana Inti Makmur Tbk PT
IDX:NASI
|
ID |
|
Deutsche Post AG
F:DPWA
|
DE |
|
Kioson Komersial Indonesia Tbk PT
IDX:KIOS
|
ID |
|
AT & S Austria Technologie & Systemtechnik AG
OTC:ASAAF
|
AT |
|
Medincell SA
PAR:MEDCL
|
FR |
|
Olam Group Ltd
F:K25
|
SG |
|
V
|
Veolia Environnement SA
XMUN:VVD
|
FR |
|
I
|
Indosat Tbk PT
F:IDO1
|
ID |
|
P
|
Philex Mining Corp
XPHS:PX
|
PH |
|
H
|
HFB Financial Corp
OTC:HFBA
|
US |
|
P
|
Pakistan Oxygen Ltd
KAR:PAKOXY
|
PK |
|
Intense Technologies Ltd
NSE:INTENTECH
|
IN |
|
K
|
Komatsu Ltd
XMUN:KOM1
|
JP |
|
Materialise NV
XBRU:MTLS
|
BE |
|
China Securities Co Ltd
SSE:601066
|
CN |
|
Gr Sarantis SA
OTC:SRTSF
|
GR |
Multiples-Based Value
The Multiples-Based Value for 
Celyad Oncology SA (1C0) under the Base Case is hidden
EUR.
Compared with the current market price of 0.18 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
1C0 Multiples-Based Value
LOCKED